It's How Medicine Should Be®

Translate

French German Italian Portuguese Russian

Treatment Study for Patients with Common Warts

Clinical Trial Title: 
A phase 3 multicenter study to evaluate the efficacy and safety of an investigational drug versus vehicle (placebo) in subjects 2 years of age or older with cutaneous common warts.
Clinical Trial Protocol ID: 
17062808
Clinical Trial Investigator Name: 
Michael D. Tharp, MD
Clinical Trial Protocol Description: 

Rush Dermatology seeks volunteers with warts for a clinical trial testing of a topical medication. All office visits and treatments are provided free of charge. Anticipated results are a possible new treatment option for patients with warts. The study will last about 30 weeks.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Have one to six clearly identifiable common warts that measure 3mm-10mm on the hands, feet, limbs, and/or trunk.
  • Are at least 2 years of age or older.
  • Are willing to stop other wart treatments

You will be excluded from the study if any of the following criteria apply to you:

  • Have more than 6 warts.

This is a partial list of elgibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.

Clinical Trial Area: 
Dermatology
Contact Email: 
Contact Phone: 
(312) 563-4001
Contact Name: 
Carmen Petrizzo or Danica Uzelac